Anaergia Valuation

ANRGF Stock  USD 0.68  0.03  4.62%   
Anaergia is overvalued. Anaergia shows a prevailing Real Value of $0.57 per share. The current price of the firm is $0.68. Our model approximates the value of Anaergia from analyzing the firm fundamentals such as profit margin of (0.21) %, and Return On Equity of -0.13 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
0.68
Please note that Anaergia's price fluctuation is out of control at this time. Calculation of the real value of Anaergia is based on 3 months time horizon. Increasing Anaergia's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Anaergia pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Anaergia. Since Anaergia is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Anaergia Pink Sheet. However, Anaergia's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  0.68 Real  0.57 Hype  0.68 Naive  0.62
The real value of Anaergia Pink Sheet, also known as its intrinsic value, is the underlying worth of Anaergia Company, which is reflected in its stock price. It is based on Anaergia's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Anaergia's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
0.57
Real Value
22.26
Upside
Estimating the potential upside or downside of Anaergia helps investors to forecast how Anaergia pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Anaergia more accurately as focusing exclusively on Anaergia's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.640.700.75
Details
Hype
Prediction
LowEstimatedHigh
0.030.6822.37
Details
Naive
Forecast
LowNext ValueHigh
0.010.6222.32
Details

Anaergia Total Value Analysis

Anaergia is presently forecasted to have takeover price of 366.53 M with market capitalization of 245.56 M, debt of 196.12 M, and cash on hands of 63.77 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Anaergia fundamentals before making investing decisions based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
366.53 M
245.56 M
196.12 M
63.77 M

Anaergia Investor Information

About 46.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.52. Some equities with similar Price to Book (P/B) outperform the market in the long run. Anaergia recorded a loss per share of 0.25. The entity had not issued any dividends in recent years. The firm had 1:4 split on the June 30, 2014. Based on the key measurements obtained from Anaergia's financial statements, Anaergia is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.

Anaergia Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Anaergia has an asset utilization ratio of 21.82 percent. This implies that the Company is making $0.22 for each dollar of assets. An increasing asset utilization means that Anaergia is more efficient with each dollar of assets it utilizes for everyday operations.

Anaergia Ownership Allocation

Anaergia holds a total of 32.19 Million outstanding shares. 30% of Anaergia outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Anaergia Profitability Analysis

The company reported the revenue of 153.58 M. Net Loss for the year was (11.21 M) with profit before overhead, payroll, taxes, and interest of 23.4 M.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Anaergia's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Anaergia and how it compares across the competition.

About Anaergia Valuation

The pink sheet valuation mechanism determines Anaergia's current worth on a weekly basis. Our valuation model uses a comparative analysis of Anaergia. We calculate exposure to Anaergia's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Anaergia's related companies.
Anaergia Inc., together with its subsidiaries, provides solutions for the generation of renewable energy and conversion of waste to resources. Anaergia Inc. was founded in 2007 and is headquartered in Burlington, Canada. Anaergia operates under Waste Management classification in the United States and is traded on OTC Exchange. It employs 345 people.

8 Steps to conduct Anaergia's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Anaergia's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Anaergia's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Anaergia's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Anaergia's revenue streams: Identify Anaergia's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Anaergia's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Anaergia's growth potential: Evaluate Anaergia's management, business model, and growth potential.
  • Determine Anaergia's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Anaergia's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Anaergia Growth Indicators

Investing in growth stocks can be very risky. If the company such as Anaergia does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding58.8 M
Forward Price Earnings8.4602
Retained Earnings-161.1 M

Complementary Tools for Anaergia Pink Sheet analysis

When running Anaergia's price analysis, check to measure Anaergia's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anaergia is operating at the current time. Most of Anaergia's value examination focuses on studying past and present price action to predict the probability of Anaergia's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anaergia's price. Additionally, you may evaluate how the addition of Anaergia to your portfolios can decrease your overall portfolio volatility.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum